Published in PLoS One on February 02, 2010
miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci U S A (2010) 3.99
MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol (2012) 3.78
Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature (2017) 2.19
MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol (2012) 2.05
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
miR-155 regulates differentiation of brown and beige adipocytes via a bistable circuit. Nat Commun (2013) 1.59
MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications. Diabetes (2011) 1.56
Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. Genome Biol (2011) 1.53
Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes (2012) 1.44
Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. PLoS One (2012) 1.41
microRNAs in the regulation of adipogenesis and obesity. Curr Mol Med (2011) 1.39
MicroRNAs in adipogenesis and as therapeutic targets for obesity. Expert Opin Ther Targets (2011) 1.22
MicroRNA regulatory networks in human adipose tissue and obesity. Nat Rev Endocrinol (2015) 1.20
MicroRNA expression in abdominal and gluteal adipose tissue is associated with mRNA expression levels and partly genetically driven. PLoS One (2011) 1.11
Oxidative stress and microRNAs in vascular diseases. Int J Mol Sci (2013) 1.10
MicroRNA 34a inhibits beige and brown fat formation in obesity in part by suppressing adipocyte fibroblast growth factor 21 signaling and SIRT1 function. Mol Cell Biol (2014) 1.09
Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity. BMC Endocr Disord (2011) 1.08
MicroRNA-27 (miR-27) targets prohibitin and impairs adipocyte differentiation and mitochondrial function in human adipose-derived stem cells. J Biol Chem (2013) 1.05
Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF-α. Diabetologia (2013) 1.03
Expression of adipose microRNAs is sensitive to dietary conjugated linoleic acid treatment in mice. PLoS One (2010) 1.02
Microvesicles/exosomes as potential novel biomarkers of metabolic diseases. Diabetes Metab Syndr Obes (2012) 1.01
Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site. Am J Hum Genet (2012) 1.01
Epigenomics, gestational programming and risk of metabolic syndrome. Int J Obes (Lond) (2015) 0.99
A Database of Gene-Environment Interactions Pertaining to Blood Lipid Traits, Cardiovascular Disease and Type 2 Diabetes. J Data Mining Genomics Proteomics (2011) 0.98
Dataset integration identifies transcriptional regulation of microRNA genes by PPARγ in differentiating mouse 3T3-L1 adipocytes. Nucleic Acids Res (2012) 0.97
MicroRNAs -the next generation therapeutic targets in human diseases. Theranostics (2013) 0.97
Circulating microRNAs have a sex-specific association with metabolic syndrome. J Biomed Sci (2013) 0.96
Genome-wide profiling of microRNAs in adipose mesenchymal stem cell differentiation and mouse models of obesity. PLoS One (2011) 0.92
Integrative miRNA-mRNA profiling of adipose tissue unravels transcriptional circuits induced by sleep fragmentation. PLoS One (2012) 0.92
MicroRNAs regulate bone metabolism. J Bone Miner Metab (2013) 0.91
Current review of genetics of human obesity: from molecular mechanisms to an evolutionary perspective. Mol Genet Genomics (2015) 0.90
Obesity gene atlas in mammals. J Genomics (2013) 0.90
microRNAs as a new mechanism regulating adipose tissue inflammation in obesity and as a novel therapeutic strategy in the metabolic syndrome. J Immunol Res (2014) 0.89
Inflammation triggers specific microRNA profiles in human adipocytes and macrophages and in their supernatants. Clin Epigenetics (2015) 0.89
Correlated mRNAs and miRNAs from co-expression and regulatory networks affect porcine muscle and finally meat properties. BMC Genomics (2013) 0.87
Regulation of SIRT1 by microRNAs. Mol Cells (2013) 0.86
Intrinsic features in microRNA transcriptomes link porcine visceral rather than subcutaneous adipose tissues to metabolic risk. PLoS One (2013) 0.86
High-throughput sequencing of microRNAs in peripheral blood mononuclear cells: identification of potential weight loss biomarkers. PLoS One (2013) 0.85
Gender and Obesity Specific MicroRNA Expression in Adipose Tissue from Lean and Obese Pigs. PLoS One (2015) 0.84
The Ups and Downs of Insulin Resistance and Type 2 Diabetes: Lessons from Genomic Analyses in Humans. Curr Cardiovasc Risk Rep (2012) 0.84
MicroRNA-181b Improves Glucose Homeostasis and Insulin Sensitivity by Regulating Endothelial Function in White Adipose Tissue. Circ Res (2016) 0.84
microRNAs as regulators of adipogenic differentiation of mesenchymal stem cells. Stem Cells Dev (2014) 0.82
miR-125a-3p and miR-483-5p promote adipogenesis via suppressing the RhoA/ROCK1/ERK1/2 pathway in multiple symmetric lipomatosis. Sci Rep (2015) 0.82
μHEM for identification of differentially expressed miRNAs using hypercuboid equivalence partition matrix. BMC Bioinformatics (2013) 0.81
Combinatorial regulation of lipoprotein lipase by microRNAs during mouse adipogenesis. RNA Biol (2014) 0.80
MicroRNAome comparison between intramuscular and subcutaneous vascular stem cell adipogenesis. PLoS One (2012) 0.80
MicroRNA transcriptomes relate intermuscular adipose tissue to metabolic risk. Int J Mol Sci (2013) 0.80
Analyses of copy number variation of GK rat reveal new putative type 2 diabetes susceptibility loci. PLoS One (2010) 0.79
MicroRNAs in soft tissue sarcomas: overview of the accumulating evidence and importance as novel biomarkers. Biomed Res Int (2014) 0.79
The expression of LEP, LEPR, IGF1 and IL10 in obesity and the relationship with microRNAs. PLoS One (2014) 0.79
Myostatin signals through miR-34a to regulate Fndc5 expression and browning of white adipocytes. Int J Obes (Lond) (2016) 0.78
Role of MicroRNAs in NAFLD/NASH. Dig Dis Sci (2016) 0.78
Genetic versus Non-Genetic Regulation of miR-103, miR-143 and miR-483-3p Expression in Adipose Tissue and Their Metabolic Implications-A Twin Study. Genes (Basel) (2014) 0.78
Adipogenic miRNA and meta-signature miRNAs involved in human adipocyte differentiation and obesity. Oncotarget (2016) 0.77
Rough sets for in silico identification of differentially expressed miRNAs. Int J Nanomedicine (2013) 0.77
Epithelial SCAP/INSIG/SREBP signaling regulates multiple biological processes during perinatal lung maturation. PLoS One (2014) 0.77
Interaction of Insulin Resistance and Related Genetic Variants With Triglyceride-Associated Genetic Variants. Circ Cardiovasc Genet (2016) 0.77
MiR-503 inhibits adipogenesis by targeting bone morphogenetic protein receptor 1a. Am J Transl Res (2016) 0.77
Gender Differences in Adipocyte Metabolism and Liver Cancer Progression. Front Genet (2016) 0.76
miR-1934, downregulated in obesity, protects against low-grade inflammation in adipocytes. Mol Cell Endocrinol (2016) 0.76
Integrative mRNA-microRNA analyses reveal novel interactions related to insulin sensitivity in human adipose tissue. Physiol Genomics (2015) 0.76
Viral mechanisms of adipose dysfunction: lessons from HIV-1 Vpr. Adipocyte (2014) 0.76
Shortcuts to a functional adipose tissue: The role of small non-coding RNAs. Redox Biol (2017) 0.75
miR-34a(-/-) mice are susceptible to diet-induced obesity. Obesity (Silver Spring) (2016) 0.75
Regulation of human adipogenesis by miR125b-5p. Adipocyte (2016) 0.75
miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease. Int J Mol Sci (2016) 0.75
A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus. Int J Mol Sci (2017) 0.75
MicroRNA-224 is Readily Detectable in Urine of Individuals with Diabetes Mellitus and is a Potential Indicator of Beta-Cell Demise. Genes (Basel) (2015) 0.75
Diet, gonadal sex, and sex chromosome complement influence white adipose tissue miRNA expression. BMC Genomics (2017) 0.75
bta-miR-23a involves in adipogenesis of progenitor cells derived from fetal bovine skeletal muscle. Sci Rep (2017) 0.75
SIRT1 and SIRT7 expression in adipose tissues of obese and normal-weight individuals is regulated by microRNAs but not by methylation status. Int J Obes (Lond) (2016) 0.75
MicroRNA 21 is up-regulated in adipose tissue of obese diabetic subjects. Nutr Healthy Aging (2017) 0.75
Fto-Deficiency Affects the Gene and MicroRNA Expression Involved in Brown Adipogenesis and Browning of White Adipose Tissue in Mice. Int J Mol Sci (2016) 0.75
Mother's Pre-pregnancy BMI and Placental Candidate miRNAs: Findings from the ENVIRONAGE Birth Cohort. Sci Rep (2017) 0.75
Obesity and p16(INK4A) Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity. Mol Cell Biol (2017) 0.75
Promising landscape for regulating macrophage polarization: epigenetic viewpoint. Oncotarget (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 96.87
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Widespread changes in protein synthesis induced by microRNAs. Nature (2008) 31.44
MicroRNAs modulate hematopoietic lineage differentiation. Science (2003) 30.05
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A (2006) 10.09
Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res (2005) 9.80
Understanding adipocyte differentiation. Physiol Rev (1998) 6.84
MicroRNA-143 regulates adipocyte differentiation. J Biol Chem (2004) 6.78
A skin microRNA promotes differentiation by repressing 'stemness'. Nature (2008) 5.66
Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res (2008) 4.95
MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene (2008) 4.11
Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes (2007) 3.87
MicroRNAs and the regulation of cell death. Trends Genet (2004) 3.42
Studies of human adipose tissue. Adipose cell size and number in nonobese and obese patients. J Clin Invest (1973) 3.21
MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes (2009) 3.02
The biology of white adipocyte proliferation. Obes Rev (2001) 2.94
Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia (2007) 2.71
Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One (2008) 2.65
Adipose tissue cellularity in human obesity. Clin Endocrinol Metab (1976) 2.58
Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J (2008) 2.58
Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst (2008) 2.20
Developmental biology. Encountering microRNAs in cell fate signaling. Science (2005) 2.20
MicroRNA and 3T3-L1 pre-adipocyte differentiation. RNA (2006) 2.00
microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem Biophys Res Commun (2009) 1.98
Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer (2009) 1.98
Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription. RNA (2008) 1.95
Hypoxia response and microRNAs: no longer two separate worlds. J Cell Mol Med (2008) 1.93
MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS One (2009) 1.81
Relation between age of onset of obesity and size and number of adipose cells. Br Med J (1972) 1.76
The growth of adipose tissue in children and adolescents. Cross-sectional and longitudinal studies of adipose cell number and size. J Clin Invest (1979) 1.57
Expression of islet-specific microRNAs during human pancreatic development. Gene Expr Patterns (2008) 1.48
MicroRNAs in the search for understanding human diseases. BioDrugs (2007) 1.47
microRNAs and cancer: role in tumorigenesis, patient classification and therapy. Clin Transl Oncol (2007) 1.29
Exaggerated replication in culture of adipocyte precursors from massively obese persons. Metabolism (1981) 1.29
New pancreas from old: microregulators of pancreas regeneration. Trends Endocrinol Metab (2007) 1.20
Thyroid hormone and adipocyte differentiation. Thyroid (2008) 1.19
Differentiation of adipocyte precursor cells from obese and nonobese adult women and from different adipose tissue sites. Horm Metab Res Suppl (1988) 1.19
Subcutaneous fat in normal and diseased states 3. Adipogenesis: from stem cell to fat cell. J Am Acad Dermatol (2007) 1.19
Lower total adipocyte number but no evidence for small adipocyte depletion in patients with type 2 diabetes. Diabetes Care (2009) 1.19
Adipogenesis: a cross-talk between cell proliferation and cell differentiation. Ann Med (2003) 1.10
Weight reduction in young obese children. I. Effects on adipose tissue cellularity and metabolism. Pediatr Res (1981) 0.86
Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab (2013) 2.64
Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev (2003) 2.58
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia. Blood (2008) 2.46
Cross-talk between iron metabolism and diabetes. Diabetes (2002) 2.36
Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects. Diabetes Care (2007) 2.05
Adipose tissue μ-crystallin is a thyroid hormone-binding protein associated with systemic insulin sensitivity. J Clin Endocrinol Metab (2014) 1.96
Targeting the circulating microRNA signature of obesity. Clin Chem (2013) 1.95
Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Diabetes Care (2014) 1.86
The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab (2008) 1.85
Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. Diabetes (2002) 1.81
Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr (2005) 1.66
Changes in circulating microRNAs are associated with childhood obesity. J Clin Endocrinol Metab (2013) 1.61
Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia. Br J Haematol (2002) 1.58
Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care (2003) 1.45
Low serum mannose-binding lectin as a risk factor for new onset diabetes mellitus after renal transplantation. Transplantation (2009) 1.44
Gene expression profiling identifies molecular pathways associated with collagen VI deficiency and provides novel therapeutic targets. PLoS One (2013) 1.44
[Factors influencing incipient diabetic nephropathy: ESODIAH study]. Med Clin (Barc) (2005) 1.38
Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein. Diabetes (2006) 1.24
Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS One (2012) 1.23
Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes Care (2009) 1.19
Serum visfatin increases with progressive beta-cell deterioration. Diabetes (2006) 1.19
Complement factor H is expressed in adipose tissue in association with insulin resistance. Diabetes (2009) 1.19
microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers. Oncol Rep (2013) 1.18
Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care (2006) 1.17
CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity. J Clin Endocrinol Metab (2003) 1.15
Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss. J Clin Endocrinol Metab (2010) 1.14
Circulating omentin concentration increases after weight loss. Nutr Metab (Lond) (2010) 1.13
The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity (Silver Spring) (2009) 1.12
CD14 modulates inflammation-driven insulin resistance. Diabetes (2011) 1.11
Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity (Silver Spring) (2011) 1.11
Does surgical resection of pulmonary metastases of head and neck cancer improve survival? Ann Surg Oncol (2008) 1.08
Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study. J Clin Endocrinol Metab (2002) 1.08
Iron stores, blood donation, and insulin sensitivity and secretion. Clin Chem (2005) 1.07
Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance? Curr Opin Clin Nutr Metab Care (2011) 1.07
Transcriptome analysis reveals altered cholesterol metabolism during the neurodegeneration in mouse scrapie model. J Neurochem (2007) 1.07
Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome. J Clin Endocrinol Metab (2009) 1.06
Salicylates increase insulin secretion in healthy obese subjects. J Clin Endocrinol Metab (2008) 1.06
Differential proteomics of omental and subcutaneous adipose tissue reflects their unalike biochemical and metabolic properties. J Proteome Res (2009) 1.06
Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. J Clin Endocrinol Metab (2006) 1.05
Abnormal expression of apoptosis-related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma. Br J Haematol (2003) 1.05
Molecular profiles and clinical outcome of stage UICC II colon cancer patients. Int J Colorectal Dis (2011) 1.05
Extracellular fatty acid synthase: a possible surrogate biomarker of insulin resistance. Diabetes (2010) 1.02
A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia (2013) 1.00
Identification and characterization of a novel spliced variant that encodes human soluble tumor necrosis factor receptor 2. Int Immunol (2004) 1.00
Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J Clin Endocrinol Metab (2003) 0.99
A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis (2003) 0.99
Serum levels of Clara cell secretory protein, asthma, and lung function in the adult general population. J Allergy Clin Immunol (2013) 0.98
OCT1 Expression in adipocytes could contribute to increased metformin action in obese subjects. Diabetes (2010) 0.98
Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes Care (2004) 0.97
Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factor. BMC Genomics (2013) 0.97
Serum interleukin-6 correlates with endothelial dysfunction in healthy men independently of insulin sensitivity. Diabetes Care (2007) 0.97
Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity. Diabetes Care (2002) 0.96
Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome. Clin Endocrinol (Oxf) (2006) 0.96
Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25). Diabetes (2006) 0.94
Structural damage in diabetic nephropathy is associated with TNF-α system activity. Acta Diabetol (2011) 0.94
Serum and urinary concentrations of calprotectin as markers of insulin resistance and type 2 diabetes. Eur J Endocrinol (2012) 0.93
Circulating retinol-binding protein-4 concentration might reflect insulin resistance-associated iron overload. Diabetes (2008) 0.92
Burden of infection and fat mass in healthy middle-aged men. Obesity (Silver Spring) (2007) 0.91
Association of circulating lactoferrin concentration and 2 nonsynonymous LTF gene polymorphisms with dyslipidemia in men depends on glucose-tolerance status. Clin Chem (2007) 0.91
Adiponectin, hepatocellular dysfunction and insulin sensitivity. Clin Endocrinol (Oxf) (2004) 0.91
Resistance training improves cardiovascular risk factors in obese women despite a significative decrease in serum adiponectin levels. Obesity (Silver Spring) (2009) 0.90
Alpha defensins 1, 2, and 3: potential roles in dyslipidemia and vascular dysfunction in humans. Arterioscler Thromb Vasc Biol (2007) 0.90
Adipocyte fatty acid-binding protein as a determinant of insulin sensitivity in morbid-obese women. Obesity (Silver Spring) (2009) 0.90
Circulating soluble CD36 is associated with glucose metabolism and interleukin-6 in glucose-intolerant men. Diab Vasc Dis Res (2009) 0.89
Attenuated metabolism is a hallmark of obesity as revealed by comparative proteomic analysis of human omental adipose tissue. J Proteomics (2011) 0.88
Both intrauterine growth restriction and postnatal growth influence childhood serum concentrations of adiponectin. Clin Endocrinol (Oxf) (2004) 0.88
FABP4 dynamics in obesity: discrepancies in adipose tissue and liver expression regarding circulating plasma levels. PLoS One (2012) 0.88
Corticosteroid-binding globulin affects the relationship between circulating adiponectin and cortisol in men and women. Metabolism (2005) 0.88
An inflammation score is better associated with basal than stimulated surrogate indexes of insulin resistance. J Clin Endocrinol Metab (2004) 0.87
Circulating soluble transferrin receptor according to glucose tolerance status and insulin sensitivity. Diabetes Care (2007) 0.87
Surfactant protein d, a marker of lung innate immunity, is positively associated with insulin sensitivity. Diabetes Care (2010) 0.87
Iron and obesity status-associated insulin resistance influence circulating fibroblast-growth factor-23 concentrations. PLoS One (2013) 0.86
Massive weight loss decreases corticosteroid-binding globulin levels and increases free cortisol in healthy obese patients: an adaptive phenomenon? Diabetes Care (2007) 0.86
Characterization of herpes virus entry mediator as a factor linked to obesity. Obesity (Silver Spring) (2009) 0.86
Study of the proinflammatory role of human differentiated omental adipocytes. J Cell Biochem (2009) 0.86
Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance. Diabetes Care (2007) 0.86
Study of lactoferrin gene expression in human and mouse adipose tissue, human preadipocytes and mouse 3T3-L1 fibroblasts. Association with adipogenic and inflammatory markers. J Nutr Biochem (2013) 0.85
Subcutaneous fat shows higher thyroid hormone receptor-alpha1 gene expression than omental fat. Obesity (Silver Spring) (2009) 0.85
Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease. Neuroreport (2006) 0.85